PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia

Data regarding the prevalence of hypertriglyceridemia in the Russian population are lacking, despite triglyceride (TG)-mediated pathways being causal in cardiovascular disease. The prevalence of mixed dyslipidemia and severe hypertriglyceridemia in the Russian population (PROMETHEUS) was undertaken...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular diabetology 2015-08, Vol.14 (1), p.115-115, Article 115
Main Authors: Karpov, Yuri, Khomitskaya, Yunona
Format: Article
Language:English
Subjects:
Adolescent
Adult
Age Distribution
Age Factors
Aged
Aged, 80 and over
Biomarkers - blood
Cardiovascular disease
Chi-Square Distribution
Cholesterol - blood
Cross-Sectional Studies
Female
Glycated Hemoglobin A - metabolism
Heart attacks
Humans
Hypertriglyceridemia - blood
Hypertriglyceridemia - diagnosis
Hypertriglyceridemia - epidemiology
Laboratories
Linear Models
Low density lipoprotein
Male
Middle Aged
Mortality
Original Investigation
Prevalence
Retrospective Studies
Risk Factors
Russia - epidemiology
Severity of Illness Index
Sex Distribution
Sex Factors
Time Factors
Triglycerides - blood
Womens health
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Data regarding the prevalence of hypertriglyceridemia in the Russian population are lacking, despite triglyceride (TG)-mediated pathways being causal in cardiovascular disease. The prevalence of mixed dyslipidemia and severe hypertriglyceridemia in the Russian population (PROMETHEUS) was undertaken to address this gap. This was an observational, cross-sectional retrospective study. Data from adults with a full/partial lipoprotein record who had blood analyses done at an INVITRO laboratory in Russia between January 1, 2011 and December 31, 2013 were analyzed. The primary endpoint was the prevalence of hypertriglyceridemia (TG ≥ 1.7 mmol/L); secondary endpoints included prevalence of borderline high, high, and very high TG and severe hypertriglyceridemia, defined as a TG level of 1.7 to
ISSN:1475-2840
1475-2840
DOI:10.1186/s12933-015-0268-2